BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9682242)

  • 1. Influence of tyrosine and phenylalanine limitation of cytotoxicity of chimeric TGF-alpha toxins on B16BL6 murine melanoma in vitro.
    Fu YM; Li YQ; Meadows GG
    Nutr Cancer; 1998; 31(1):1-7. PubMed ID: 9682242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells.
    Mesri EA; Kreitman RJ; Fu YM; Epstein SE; Pastan I
    J Biol Chem; 1993 Mar; 268(7):4853-62. PubMed ID: 8444864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine and phenylalanine restriction induces G0/G1 cell cycle arrest in murine melanoma in vitro and in vivo.
    Fu YM; Yu ZX; Ferrans VJ; Meadows GG
    Nutr Cancer; 1997; 29(2):104-13. PubMed ID: 9427972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine and phenylalanine restriction sensitizes adriamycin-resistant P388 leukemia cells to adriamycin.
    Elstad CA; Thrall BD; Raha G; Meadows GG
    Nutr Cancer; 1996; 25(1):47-60. PubMed ID: 8837861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of B16BL6 melanoma invasion by tyrosine and phenylalanine deprivation is associated with decreased secretion of plasminogen activators and increased plasminogen activator inhibitors.
    Pelayo BA; Fu YM; Meadows GG
    Clin Exp Metastasis; 1999; 17(10):841-8. PubMed ID: 11089882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic stability of B16-BL6 melanoma exposed to low levels of tyrosine and phenylalanine.
    Elstad CA; Meadows GG
    Anticancer Res; 1990; 10(5A):1313-8. PubMed ID: 2241108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential growth factor production, secretion, and response by high and low metastatic variants of B16BL6 melanoma.
    Blanckaert VD; Schelling ME; Elstad CA; Meadows GG
    Cancer Res; 1993 Sep; 53(17):4075-81. PubMed ID: 8358737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of B16-BL6 murine melanoma metastatic phenotype by tyrosine and phenylalanine restriction in the absence of host selection pressures.
    Elstad CA; Meadows GG
    Anticancer Res; 1993; 13(2):523-8. PubMed ID: 8517667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
    Phillips PC; Levow C; Catterall M; Colvin OM; Pastan I; Brem H
    Cancer Res; 1994 Feb; 54(4):1008-15. PubMed ID: 8313355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
    Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
    Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency.
    Fu YM; Yu ZX; Pelayo BA; Ferrans VJ; Meadows GG
    Cancer Res; 1999 Feb; 59(3):758-65. PubMed ID: 9973229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-binding EGF-like growth factor is an autocrine growth factor for rat gastric epithelial cells.
    Miyazaki Y; Shinomura Y; Higashiyama S; Kanayama S; Higashimoto Y; Tsutsui S; Zushi S; Taniguchi N; Matsuzawa Y
    Biochem Biophys Res Commun; 1996 Jun; 223(1):36-41. PubMed ID: 8660375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic effects of vascular smooth muscle cells of the chimeric toxin, heparin binding TGF alpha-Pseudomonas exotoxin.
    Fu YM; Mesri EA; Yu ZX; Kreitman RJ; Pastan I; Epstein SE
    Cardiovasc Res; 1993 Sep; 27(9):1691-7. PubMed ID: 8287449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of caspases and cleavage of Bid are required for tyrosine and phenylalanine deficiency-induced apoptosis of human A375 melanoma cells.
    Ge X; Fu YM; Li YQ; Meadows GG
    Arch Biochem Biophys; 2002 Jul; 403(1):50-8. PubMed ID: 12061801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of transforming growth factor beta 1 on the growth of poorly and highly metastatic murine melanoma cells.
    Mooradian DL; Purchio AF; Furcht LT
    Cancer Res; 1990 Jan; 50(2):273-7. PubMed ID: 2295066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary restriction of tyrosine and phenylalanine: inhibition of metastasis of three rodent tumors.
    Abdallah RM; Starkey JR; Meadows GG
    J Natl Cancer Inst; 1987 Apr; 78(4):759-69. PubMed ID: 3470551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
    Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
    Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
    Pierson HF; Meadows GG
    Cancer Res; 1983 May; 43(5):2047-51. PubMed ID: 6831435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-binding epidermal growth factor-like growth factor, an immediate-early gene for mesangial cells, is up-regulated in the Thy-1.1 model.
    Polihronis M; Murphy BF; Pearse MJ; Power DA
    Exp Nephrol; 1996; 4(5):271-8. PubMed ID: 8931982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
    Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
    J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.